| Drug Type CAR-T | 
| Synonyms GPA TriMAR T cell therapy, GPA-TriMAR-T, TCR-mimic-CAR-T + [3] | 
| Target | 
| Action inhibitors | 
| Mechanism gp100 inhibitors(Melanocyte protein PMEL inhibitors), Gene transference(Gene transference), T lymphocyte replacements | 
| Therapeutic Areas | 
| Active Indication- | 
| Inactive Indication | 
| Originator Organization | 
| Active Organization- | 
| Inactive Organization | 
| License Organization- | 
| Drug Highest PhaseDiscontinuedEarly Phase 1 | 
| First Approval Date- | 
| Regulation- | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Melanoma | Phase 1 | China  | 27 Sep 2018 | |
| Melanoma | Phase 1 | China  | 27 Sep 2018 | 





